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Abstract: The present study uniquely examined the effect of 3 mg·kg−1 chronic caffeine consump-
tion on training adaptations induced by 7-weeks resistance training and assessed the potential for
habituation to caffeine’s ergogenicity. Thirty non-specifically resistance-trained university standard
male rugby union players (age (years): 20 ± 2; height (cm): 181 ± 7; body mass (kg): 92 ± 17)
completed the study), who were moderate habitual caffeine consumers (118 ± 110 mg), completed
the study. Using a within-subject double-blind, placebo-controlled experimental design, the acute
effects of caffeine intake on upper and lower limb maximal voluntary concentric and eccentric
torque were measured using isokinetic dynamometry (IKD) prior to and immediately following a
resistance training intervention. Participants were split into strength-matched groups and completed
a resistance-training program for seven weeks, consuming either caffeine or a placebo before each
session. Irrespective of group, acute caffeine consumption improved peak eccentric torque of the
elbow extensors (p < 0.013), peak concentric torque of the elbow flexors (p < 0.005), total eccentric
work of the elbow flexors (p < 0.003), total concentric work of the knee extensors (p < 0.001), and total
concentric and eccentric work of the knee flexors (p < 0.046) following repeated maximal voluntary
contractions. Many of these acute caffeine effects were still prevalent following chronic exposure to
caffeine throughout the intervention. The training intervention resulted in significant improvements
in upper and lower body one-repetition maximum strength (p < 0.001). For the most part, the effect of
the training intervention was equivalent in both the caffeine and placebo groups, despite a small but
significant increase (p < 0.037) in the total work performed in the participants that consumed caffeine
across the course of the intervention. These results infer that caffeine may be beneficial to evoke acute
improvements in muscular strength, with acute effects prevalent following chronic exposure to the
experimental dose. However, individuals that consumed caffeine during the intervention did not
elicit superior post-intervention training- induced adaptations in muscular strength.
Keywords: resistance exercise; strength; power; ergogenic aids; performance
1. Introduction
A wealth of scientific evidence, summarised in a recent umbrella review [1], docu-
ments small but significant improvements in aerobic endurance [2], anaerobic power [2,3],
muscular endurance and strength [4,5], and sport-specific skills [6] following acute caffeine
ingestion. Given caffeine’s widespread performance-enhancing benefits, it is a popular
ingredient in many commercially available products targeted to augment adaptions evoked
by exercise training. Most previous research has focused on acute caffeine effects on a
single exercise bout [2,7,8]. However, there is a dearth of evidence examining if such
acute benefits applied over the long-term can manifest in enhanced, chronic adaptations to
exercise training.
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Several meta-analyses have reported an ergogenic effect of acute caffeine ingestion
for muscular strength [1,3,5]. Due to these acute effects, it would seem intuitive that
improved performance in a bout of resistance exercise multiplied over the duration of a
resistance training regime may evoke an elevated training response [9]. However, this
assumption has not been thoroughly explored and the potential beneficial response of
caffeine during chronic exposure may be offset by habituation to its effects. Although
a point of contention [10–12] there is evidence to suggest that chronic consumption of
3 mg·kg−1 of caffeine in low habitual caffeine users (<75 mg/day−1) results in intolerance
after 4 weeks [13]. Furthermore, in some cases, acute effects of caffeine on exercise perfor-
mance are not demonstrated in high habitual users (426 mg/day) [14]. Direct comparisons
are challenging given the lack of standardised thresholds for determining high and low
habitual caffeine use [15]. However, confounding ideas surrounding the chronic use of
caffeine for exercise performance would appear to work in paradox, inciting a need for
further investigation.
Only two studies examined if chronic caffeine ingestion can augment resistance train-
ing adaptations. In resistance-trained males, Kemp et al. [9] demonstrated that 3 mg·kg−1
of caffeine consumed before every exercise session resulted in superior improvements in
the bench press and squat one repetition maximum (1RM) compared to the placebo group
following 6 weeks of resistance training. Using the same dose and a similar population,
recent work by Giráldez-Costas et al. [16] indicated no significant difference in training-
induced adaptions in bench press 1RM between groups ingesting either caffeine or placebo
during a 4-week resistance training intervention. However, the group ingesting caffeine
had a more pronounced improvement in movement velocity when assessed across the
force-velocity spectrum.
The disparity in caffeine-induced improvements in maximal strength may be related
to the difference in the training regimes and duration of the program. Furthermore,
previous studies did not account for baseline strength when assigning participants to
training groups, which may have influenced the results. Given the limited research in the
area and the inconclusive findings, further investigation is required. Whilst these initial
studies offer important insight, work is now needed to understand if chronic caffeine
consumption during resistance training induces regional and contractile mode-specific
changes given that caffeine’s effect on strength may differ between concentric and eccentric
models of activity, contractile velocity, and specific muscle groups [17–20]. Furthermore,
previous work fails to consider intersessional performance between caffeine and placebo
groups across the course of the training intervention, which is an important driver to
enhance resistance-training adaptation. Moreover, previous studies also fail to consider the
potential impact of habituation, which may limit the proposed benefits of chronic caffeine
supplementation. For this to be achieved, a more complex within and between subject’s
experimental design is needed.
Given the outlined important gaps in the literature, the aims of the present study
were threefold: (1) using a within-subjects experimental design the present work sought
to assess the acute effect of 3 mg·kg−1 of caffeine consumption on the maximal voluntary
concentric and eccentric strength of the knee and elbow flexors and extensors in a pop-
ulation of male rugby union players; (2) using a between-subjects experimental design
to assess the effects of 3 mg·kg−1 of caffeine consumption on adaptations to a 7-week
resistance training program in participants matched for baseline strength; (3) using a
within-subjects experimental design to reassess the acute effect of 3 mg·kg−1 of caffeine
consumption on the maximal voluntary concentric and eccentric strength of the knee and
elbow flexors and extensors post completion of the training regime. As such, the present
work provides the most detailed examination of the effects of chronic caffeine consumption
on regional and contractile mode-specific adaptations to resistance training and uniquely
considers the impact of caffeine habituation in inhibiting augmentation of the training
response. It was hypothesised that (1) acute caffeine consumption would evoke improved
muscular strength, which would manifest in a small but significant superior training adap-
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tations; (2) that the group that consumed caffeine during the training intervention would
demonstrate a reduced acute effect of caffeine on measures of muscular strength following
the intervention.
2. Materials and Methods
2.1. Participants
Following ethics approval from Coventry University (reference code; P76381; ap-
proved on 3/12/2018) and informed consent, 40 apparently healthy participants from the
Coventry University Men’s rugby union team agreed to participate in the study. The cur-
rent study was also in compliance with the declaration of Helsinki [21]. Participants trained
with the team twice per week and played competitively once per week. This continued
throughout the duration of the study. Potential participants were excluded if they were:
suffering from a musculoskeletal injury that prevented safe completion of the exercise
trials; were consuming psychoactive medication; had any other underlying contradictions
to exercise; or habitually consumed high levels of caffeine (i.e., >6.00 mg/ kg/day) [15].
Participants completed a health screen questionnaire prior to each visit. Over the course
of the investigation, 10 participants dropped out due to injury (n = 3) (not related to the
experimental protocol), illness (n = 2), or for reasons not stated (n = 5) leaving a total sample
of 30 (mean ± standard deviation (SD); Age (years): 20 ± 2; height (cm): 181 ± 7; body
mass (kg): 92 ± 17).
2.2. Experimental Design
Following baseline assessments of maximal strength and a familiarisation trial, the
acute effects of caffeine on maximal strength were assessed, which was immediately fol-
lowed by chronic caffeine consumption through a resistance training program (Figure 1).
Finally, the acute effects of caffeine on muscular strength were reassessed following com-
pletion of the training program.
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Figure 1. Schematic of experimental design.
Prior to the assessment of the acute effects of caffeine, participants were asked to
abstain from caffeine at least 12 h b fore t sting and intense physical activity at le st 48 h
prior. As utlined b low, when prescribed participants consumed caffeine (3 mg·kg−1;
Myp otein, UK) or a placebo (3 mg·kg−1; maltodextrin; Myprot in, UK) issued in a trans-
pa ent capsule (BulkTM, UK). The ergogenic effect of caffein supplementation at this dose
is well established [3,22,23], and also clos ly represe ts a dos achievable without the need
for caffeine anhydrous.
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2.3. Acute Effect of Caffeine on Upper and Lower Body Strength
The acute effects of caffeine on muscular strength were assessed using a double-blind,
randomised, and counterbalanced within-subject experimental design. For this part of the
study, the participants were asked to visit the human performance laboratory at Coventry
University for one familiarisation and two experimental trials (i.e., caffeine and placebo
ingestion).
2.4. Familiarisation
The first visit was to familiarise participants with the experimental procedures to
be used for the assessment of the acute caffeine effect. Initially, assessments were made
barefoot in shorts and a t-shirt, and measures of height (cm) and body mass (kg) were taken
using a SECA 213 portable stadiometer (SECA 213, Hamburg, Germany) and electronic
weighing scales (SECA 803, Hamburg, Germany), respectively. Participants were then
asked to complete a caffeine consumption questionnaire [24] to determine typical caffeine
consumption habits and a caffeine expectancy questionnaire [25] to determine their per-
ception of caffeine as a performance enhancer. The caffeine expectancy questionnaire con-
sisted of 47 questions, which were categorised into the following: withdrawal/dependence
(12 questions), energy/work enhancement (8 questions), appetite suppression (5 questions),
social mood enhancement (6 questions), physical performance enhancement (3 questions),
anxiety/negative physical effect (9 questions), and sleep disturbance (4 questions). Par-
ticipants were asked to respond to statements using the following cues: “very unlikely”,
“unlikely”, “a little unlikely”,” a little likely”, “likely”, and very likely”. These answers
were then transformed into a number with 1 being “very unlikely” and 6 being “very
likely” [25]. Scores from each subsection were averaged for each individual.
2.5. Warm-Up
Prior to completion of the physical assessments, participants were asked to complete
a standardised warm-up of the upper and lower body. The upper body warm-up con-
sisted of 5 min of arm crank ergometry (Lode, Angio) with an unloaded cradle fixed at
70 revs·min−1, followed by static and dynamic stretching of the elbow flexors (biceps
brachii and brachialis). Then, the participants completed a lower-body warm-up that
consisted of 5 min of cycling on an exercise ergometer (Monark 824E Ergomedic) with
an unloaded cradle fixed at 70 revs·min−1 immediately followed by static and dynamic
stretching, focusing on the knee extensors (vastus intermedius, vastus medialis, vastus
lateralis, and rectus femoris).
2.6. Isokinetic Strength Assessment
After completing the warm-up procedure, participants completed the strength assess-
ment. Skeletal muscle contractile performance was assessed using isokinetic dynamometry
in accordance with previously published protocols [18,20,22]. Isokinetic dynamometry
is commonly used to evaluate muscular strength [26] and has shown good test-retest
reliability in similar populations [27,28]. Furthermore, evidence suggests that a single
familiarisation session in athletes adequately addresses potential learning effects for mea-
sures of peak torque [29].
Maximal voluntary isokinetic torque (Nm) of the elbow flexors and extensors for the
dominant side was measured using an isokinetic dynamometer (Humac Norm, CSMi,
model 502140, Stoughton, MA, USA) set up following the manufacturer’s instructions.
The rotational axis of the dynamometer head was aligned with the lateral epicondyle
of the humerus on the dominant side, with an elbow rest positioned relative to this. A
handgrip bar at the opposing end of the lever arm was adjusted relative to the length
of the hand and forearm to allow the participant a comfortable grip. During concentric
measures, participants were instructed to pull upwards on the bar as hard a possible
through a fixed range of motion (80◦–120◦ relative to anatomic zero). During eccentric
measures, participants were asked to resist the movement of the lever arm moving through
Nutrients 2021, 13, 3367 5 of 23
the same range of motion. Average and maximal concentric and eccentric forces were
measured at fixed angular velocities of 60, 120, and 180 deg/s. Participants warmed up
with 3 submaximal attempts at each speed to become familiarised with the movements and
test speeds. During the assessment of maximal voluntary torque, participants performed
3 attempts separated by 60-s rest. The best attempt of the three was used for the analysis.
Each speed was separated by a two-minute rest period. Following the measure of maximal
concentric and eccentric force, the participants performed 3 sets of 10 maximal repetitions
at 60 deg/s with individual repetitions being summed across the 30 repetitions. Each set
was separated by 10 s. All torque values collected were corrected for gravity effects by
estimation of limb weight prior to the assessment of maximal voluntary torque. Following
each set, Rate of Perceived Exertion (RPE) was measured [30].
Participants then completed an assessment of the maximal voluntary isokinetic torque
(Nm) of the knee flexors and extensors. Each participant was strapped to the dynamometer
chair in a seated position, and the lever arm axis of rotation was aligned with the lateral
femoral epicondyle of the dominant limb. The distal end of the lever arm was fitted with
a shin pad which was aligned with the lateral malleolus. A strap was placed across the
midpoint of the upper limb of the participant’s dominant leg. Throughout the testing,
participants were instructed to keep their arms fixed across the chest. The range of motion
was fixed at 10◦–80◦ relative to anatomic zero. The testing protocol was then carried out
in the way that described for the assessment of maximal voluntary torque of the elbow
flexors and extensors.
2.7. Experimental Trials
The experimental protocol followed the procedure outlined above but was proceeded
by a treatment ingestion period (Figure 2). Participants consumed either 3 mg·kg−1 caffeine
or a placebo 45 min prior to completion of the warm-up. Treatments were issued 45 min
prior to the warm-up so that the experimental trial commenced 60 min post-ingestion.
Previous work indicates that maximal blood plasma concentration of caffeine occurs
60 min post-consumption [23]. Readiness to Invest Effort (RTE) [31] and Felt Arousal
Scale (FAS) [32] were measured pre-consumption, 15, 30, and 45 min after consumption.
An analogue scale was used to measure RTE with a scale from “not ready at all” to
“totally ready”. A scale of 1–6 was used for FAS with 1 being “low arousal” and 6 being
“high arousal”.
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2.8. Chronic Effects of Caffeine Ingestion during a 7-Week Resistance Training Program
To assess if chronic caffeine ingestion can augment adaptations to resistance training,
a between subject’s experimental design was conducted. Participants were randomly split
into a control (n = 15) or caffeine (n = 15) group. Groups were matched based on habitual
caffeine use, using the data obtained from the caffeine consumption questionnaire, and for
baseline strength, using the procedures outlined in the statistical method. Following the
assessment of 1RM, all participants then completed the same training regime as indicated
below (Figure 3).





Figure 3. Schematic of Resistance training sessions. 
  
Figure 3. Schematic of Resistance training sessions.
2.9. Assessment of 1 Repetition Maximum
1RM values in the six exercises were assessed over two visits to program the training
regime and as an additional baseline marker of muscular strength. On the initial visit, the
researcher provided a demonstration of the correct lifting techniques for all used exercises.
For all exercises, participants then completed 8–10 unweighted repetitions to ensure the
correct lifting technique was achieved. Participants completed assessments of 1RM for
squats (SQ), deadlifts (DL), chest press (CP), seated shoulder press (SSP), power clean (PC),
and hang clean (HC). All exercises were completed using a 20 kg Eleiko barbell and in
accordance with published protocols [33–35]. Prior to 1RM attempts participants started
at 50% of estimated 1RM for 3–5 repetitions, progressing to 70% for 1–3 repetitions, and
90% for 1 repetition. All 1RM values were determined by progressively increasing the
weight (e.g., 5 kg per attempt) lifted until the participant failed to lift the set weight through
a full range of motion and using the correct form [36,37]. A trained researcher/ spotter
was present during all testing sessions to ensure a proper range of motion. Any lift that
deviated from proper technique was not counted. This included a lack of full range of
motion exhibited during the lift or technique that did not conform to guidelines for the
execution of the exercise in question as defined by Baechle and Earle [38]. This procedure
was then repeated on the second visit, which occurred at least 2 days later. A minimum of
1 min of rest was permitted between attempts and a minimum of 5 min rest between lifts.
Lifts were altered between the upper and lower body to reduce fatigue and their order was
consistent in each testing session.
2.10. Resistance Training Intervention (7-Weeks)
The effect of caffeine on resistance training was assessed using a double-blind, between-
subject experimental design. Participants were asked to abstain from caffeine 12 h prior
to the commencement of each training session. Forty-five minutes before the commence-
ment of each training session participants in the caffeine group consumed 3 mg·kg−1
Nutrients 2021, 13, 3367 7 of 23
caffeine and those in the placebo group an equivalent dose of maltodextrin in the same
manner as previously outlined. The intention of the resistance training intervention was to
develop upper and lower body maximal strength and strength endurance. Following a
standardised warm-up consisting of static and dynamic stretches focusing on the upper
and lower body muscles participant completed a circuit training program consisting of
8 exercises. The exercises were CP, SSP, SQ, DL, PC, HC, sit up, and press-ups. The load for
CP, SSP, SQ, DL, PC, HC was set at 70% of 1RM; sit-ups and press-ups were performed
without any external load. Throughout the course of the intervention, all exercises were
performed with “repetitions until failure” (RTF), meaning that the participants lifted 70%
of 1RM until exhaustion. Previous resistance training interventions commonly used loads
of 60–80% of 1RM [39–42] given that such loads have been shown to increase muscular
strength [38,43]. Previous work has demonstrated that resistance training intervention im-
plementing repetitions until failure protocols are effective for improving muscular strength
and strength endurance [44–46]. Repetitions until failure was favoured over protocols
using a fixed training load given that the open-ended nature of repetitions until failure
protocol allowed for a more robust assessment of the effect of acute caffeine consumption
across the course of the training intervention. All participants completed two circuits of all
8 exercises, alternating between upper and lower body exercises. A minimum of 2 min rest
was provided between exercises and 10 min rest between circuits. The number of successful
repetitions and RPE were collected after each exercise. Circuit training sessions took place
Tuesday morning and Thursday evening for 7-weeks. Previous work has shown that
resistance-training interventions of similar duration are effective in increasing muscular
strength [9,41,47]. Upon completion of the 7-week intervention training programme, all
participants completed reassessments 1RM.
2.11. Statistical Analysis
Data analysis was performed using Statistical Package for the Social Sciences (IBM
SPSS Statistics Version 25) and Excel (Microsoft Windows Version 16.41 2020). Initially,
appropriate tests of normality and homogeneity were performed. To match groups for
baseline strength prior to completion of the resistance training program, a Pearson’s or
Spearman’s correlation was performed between all measures of 1RM. All measures, other
than DL and PC (R = 0.364 p = 0.048) and DL and HC (R = 0.239, p = 0.203), were significantly
correlated (R = 0.463–0.820, p < 0.05 in all cases). Given that 28 of 30 1RM comparisons
demonstrated a significant correlation, all the data were transformed to a Z-score using
the formula (x-µ)/σ, summed and compared using an independent sample t-test. The
acute effects of caffeine on measures of peak torque (PT), total work (TW), and RPE, were
assessed using a 4-factor mixed-model ANOVA. The between factor being Group (caffeine
and placebo) and within factors being Time (pre-and post-intervention), Treatment (caffeine
or placebo), and Speed/Set (60, 120, and 180/Set 1, Set 2, and Set 3). Furthermore, RTE
and FAS were assessed using a 4-factor mixed-model ANOVA. The between factor being
Group (caffeine and placebo) and within factors being Time (pre-and post-intervention),
Treatment (caffeine or placebo), and Minutes (pre, 15, 30, and 45-min post-ingestion).
Maximal strength (i.e., 1RM) measures were assessed using a single factor ANOVA with
the fixed factor of Time (pre-and post-intervention). All intervention data (RTF and RPE)
were analysed using an imputation method [48,49] followed by a 3-factor mixed model
ANOVA with a between factor of Group (caffeine or placebo) and within factors of Session
(1–14) and Set (Set1 and Set2). All violations of sphericity were adjusted using Greenhouse–
Geisser where appropriate. Relevant main effects and significant interactions were further
analysed in a Bonferroni adjusted pairwise comparison. Cases of violated normality were
present; however, ANOVA was still considered a robust method of statistical analysis in
such cases [50]. Partial eta squared (η2) was reported with significant ANOVA main effects
as a measure of effect size [51]. Additionally, effect size (d) from the pairwise comparison
(bias-corrected (Hedges) was calculated using the difference in means divided by the
SD of the compared variables. Effect size was reported using the following categories:
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trivial < 0.20, small 0.20–0.49, medium 0.50–0.79, and large > 0.80 [52]. Data were presented
as Mean ± SD with statistical significance set at a level of p < 0.05.
3. Results
3.1. Participation Characteristics
Age (caffeine group: 20 ± 2 years; placebo group: 19 ± 2 years; p = 0.66), height (caf-
feine group: 181 ± 8 cm; placebo group: 181 ± 5 cm; p = 0.78), or body mass (caffeine group:
89 ± 10 kg; placebo group: 95 ± 22 kg; p = 0.30) did not differ between individuals assigned
to the caffeine or placebo groups. Average caffeine consumption was 133 ± 123 mg per
day and 121 ± 95 mg per day for the caffeine and placebo groups, respectively, with four
participants reporting no caffeine use (caffeine group n = 2; placebo group n = 2). Average
caffeine consumption did not differ between groups (p = 0.888, d = 0.11). The perceived
effect of caffeine in energy/work enhancement and sleep disturbance were significantly
higher in the placebo group (Table 1: p < 0.045, d = 0.97); however, there were no other sig-
nificant differences for any other caffeine expectancy subscale (Table 1: p < 0.744, d < 0.97).
Baseline strength was comparable between the groups prior to completing the resistance
training program (p = 0.40, d > 0.31).





Caffeine Intake 133 ± 123 mg/day 121 ± 95 mg/day
Withdrawal/ Dependence (n = 12) 2 ± 1 2 ± 1
Energy/ Work Enhancement (n = 8) 4 ± 1 5 ± 1
Appetite Suppression (n = 5) 2 ± 1 3 ± 1
Social mood Enhancement (n = 6) 3 ± 1 3 ± 1
Physical Performance Enhancement (n = 3) 3 ± 1 4 ± 1
Anxiety/ Negative Physical Effect (n = 9) 2 ± 1 2 ± 1
Sleep Disturbance (n = 4) 3 ± 1 4 ± 1
Total Questions (n = 47)
Note: Values are represented as means ± SD, n = number of questions.
3.2. Peak Torque
3.2.1. Elbow Extension Peak Torque
For eccentric PT of the elbow extensors, there was a significant Treatment*Speed
interaction (Table 2: p = 0.001, ηp2 = 0.336). Pairwise comparison indicated that eccentric
PT at 120 and 180◦/s was higher following caffeine supplementation compared to placebo
(Table 2: p < 0.013, d > 0.24). Furthermore, eccentric PT was greater at 180◦/s compared
to that at 60 and 120◦/s, but only in the caffeine trial (Table 2: p < 0.005, d > 0.17). For
both concentric and eccentric PT there were no other significant interactions (Table 2:
p > 0.055, ηp2 < 0.098). Concentric PT was significantly affected by Speed (Table 2: p = 0.001,
ηp
2 = 0.708) with PT at 180◦/s being lower than that at 60 and 120◦/s (Table 2: p < 0.001 in
both cases). There were no other significant main effects (Table 2: p > 0.208, ηp2 < 0.088).
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Table 2. Acute effect of caffeine treatment (3 mg·kg−1) pre and post-7-week of resistance training on concentric and eccentric
PT (Nm) of the elbow and knee flexors and extensors.
Caffeine Intervention Group Placebo Intervention Group
Angular Velocity
(Deg/s)
Acute Placebo Acute Caffeine Acute Placebo Acute Caffeine
Pre-Int Post-Int Pre-Int Post-Int Pre-Int Post-Int Pre-Int Post-Int
Elbow Extension
Con 60 38 ± 8 42 ± 8 41 ± 12 40 ± 7 36 ± 10 41 ± 11 42 ± 14 42 ± 10
120 32 ± 8 38 ± 9 38 ± 14 35 ± 6 30 ± 9 35 ± 11 36 ± 14 38 ± 8
180 30 ± 6 32 ± 7 33 ± 15 32 ± 6 30 ± 9 32 ± 8 32 ± 8 36 ± 8
Ecc 60 44 ± 11 48 ± 9 50 ± 16 46 ± 10 46 ± 18 48 ± 15 51 ± 17 49 ± 17
120 40 ± 10 * 46 ± 8 ˆ 56 ± 19 * 48 ± 8 ˆ 41 ± 22 * 49 ± 13 ˆ 52 ± 13 * 54 ± 25 ˆ
180 40 ± 10 * 49 ± 10 ˆ 59 ± 20 * 50 ± 11 ˆ 44 ± 28 * 51 ± 14 ˆ 55 ± 16 * 62 ± 27 ˆ
Elbow Flexion
Con 60 51 ± 7 *# 56 ± 10 ˆ# 58 ± 16 *# 56 ± 9 ˆ# 51 ± 10 56 ± 15 60 ± 16 # 61 ± 18 #
120 50 ± 10 *# 51 ± 9 ˆ# 52 ± 15 *# 53 ± 10 ˆ# 45 ± 11 54 ± 16 55 ± 15 # 58 ± 11 #
180 45 ± 8 # 48 ± 7 ˆ# 48 ± 15 # 49 ± 9 # 50 ± 12 49 ± 14 41 ± 11 # 50 ± 10 #
Ecc 60 54 ± 15 59 ± 12 61 ± 15 63 ± 21 62 ± 17 68 ± 22 64 ± 16 67 ± 21
120 61 ± 17 59 ± 12 61 ± 15 63 ± 16 59 ± 13 68 ± 20 68 ± 19 70 ± 19
180 61 ± 14 63 ± 10 61 ± 14 66 ± 14 65 ± 11 70 ± 17 62 ± 20 72 ± 19
Knee Extension
Con 60 147 ± 47 # 181 ± 67 # 167 ± 61 188 ± 69 179 ± 59 187 ± 49 190 ± 41 175 ± 41
120 139 ± 49 # 160 ± 56 # 150 ± 50 177 ± 62 153 ± 70 159 ± 65 166 ± 51 149 ± 41
180 121 ± 46 # 142 ± 52 # 126 ± 58 141 ± 49 140 ± 54 122 ± 37 146 ± 63 126 ± 48
Ecc 60 156 ± 56 187 ± 66 187 ± 76 203 ± 73 192 ± 74 211 ± 72 212 ± 74 205 ± 52
120 167 ± 54 174 ± 50 192 ± 75 221 ± 69 207 ± 76 208 ± 64 227 ± 88 189 ± 49
180 161 ± 72 183 ± 46 202 ± 61 206 ± 60 225 ± 82 200 ± 61 230 ± 89 200 ± 52
Knee Flexion
Con 60 92 ± 33 # 112 ± 37 # 103 ± 31 124 ± 38 111 ± 44 # 115 ± 45 # 119 ± 42 120 ± 45
120 90 ± 32 # 106 ± 33 # 100 ± 37 119 ± 21 100 ± 40 # 107 ± 42 # 100 ± 35 100 ± 36
180 80 ± 27 # 96 ± 26 # 89 ± 34 105 ± 25 87 ± 36 # 97 ± 32 # 97 ± 34 97 ± 32
Ecc 60 99 ± 37 125 ± 40 115 ± 36 135 ± 52 125 ± 47 140 ± 56 132 ± 45 142 ± 46
120 98 ± 40 126 ± 46 121 ± 40 145 ± 37 125 ± 42 130 ± 50 119 ± 44 137 ± 50
180 92 ± 27 119 ± 39 113 ± 30 142 ± 37 120 ± 43 128 ± 40 122 ± 40 138 ± 54
Note: Values are represented as means ± SD, PT = Peak Torque, Con = Concentric, Ecc = Eccentric, Pre-Int= Pre-training intervention, and
Post-Int= Post-training intervention, matching * represents a significant effect of caffeine prior to the intervention, matching ˆ represents a
significant effect of caffeine post-intervention, matching # represents a significant difference on peak torque post the intervention.
3.2.2. Elbow Flexion Peak Torque
For concentric PT of the elbow flexors, there was a significant Group*Time*Treatment
interaction (Table 2: p = 0.024 ηp2 = 0.168) and for both concentric and eccentric PT a
significant Time*Treatment*Speed interactions (Table 2: p < 0.034 ηp2 > 0.112). Pairwise
comparisons indicated that for the caffeine group, concentric PT was higher post inter-
vention and increased in the placebo group but only when the pre to post caffeine trail
was compared (Table 2: p < 0.008, d > 0.17). Eccentric PT was not significantly increased
post-intervention (Table 2: p > 0.094, d < 0.53) and was not affected by acute caffeine
treatment either pre- or post-the intervention (Table 2: p > 0.209, d < 0.35). However, acute
caffeine treatment increased concentric PT measured at 60 and 120◦/s both pre and post
the training intervention (Table 2: p < 0.005, d > 0.19). In some cases, PT was affected by
speed. Following the intervention concentric PT at 180◦/s was higher than that at 60 and
120◦/s (Table 2: p < 0.003 in both cases) and following the placebo treatment PT at 60◦/s
was higher than 120 and 180◦/s (Table 2: p < 0.030, d > 0.09).
Nutrients 2021, 13, 3367 10 of 23
3.2.3. Knee Extension Peak Torque
For eccentric PT of the knee extensors, there was a significant Group*Time*Treatment
*Speed interaction (Table 2: p = 0.016 ηp2 = 0.138). Pairwise comparison indicated that the
caffeine group had an increase in PT at 60◦/s post the exercise intervention at a level that
was approaching significant (Table 2: p = 0.053, d > 0.22), whereas the placebo group had no
significant training effect (Table 2: p = 0.083, d > 0.09). There was no effect of acute caffeine
supplementation or speed (Table 2: p > 0.166 ηp2 < 0.001). For concentric PT, there was a
significant Group*Time interaction (Table 2: p = 0.010 ηp2 = 0.212). Pairwise comparison
indicated PT was improved following the intervention in the caffeine group (Table 2:
p = 0.010, d > 0.27) but unchanged in the placebo group (Table 2: p = 0.275, d < 0.47). For
concentric PT, there were no other significant interactions (Table 2: p > 0.097 ηp2 < 0.114)
or a main effect of acute caffeine treatment (Table 2: p = 0.344 ηp2 = 0.114). However, PT
was significantly affected by Speed (Table 2: p = 0.001 ηp2 = 0.665) with PT at 180◦/s being
lower than that at 60 and 120◦/s (Table 2: p < 0.001 in both cases d > 0.27).
3.2.4. Knee Flexion Peak Torque
For concentric and eccentric PT of the knee flexors there were no significant inter-
actions (Table 2: p > 0.094 ηp2 > 0.002) and no main effect of Group (Table 2: p > 0.417
ηp
2 > 0.004). For concentric PT, there was no main effect of Treatment (Table 2: p = 0.075
ηp
2 = 0.109), but there was a main effect of Time (Table 2: p = 0.007 ηp2 = 0.230) with PT
post the exercise intervention being significantly higher than pre-intervention exercise.
There was also a main effect of Speed (Table 2: p = 0.001 ηp2 = 0.418) with performance at
180◦/s being lower than that at 60 and 120◦/s (Table 2: p < 0.003 in both cases d > 0.16). For
eccentric PT, there was no main effect of Speed (Table 2: p = 0.316 ηp2 = 0.040). However,
there was a main effect with treatment (Table 2: p = 0.007 ηp2 = 0.223) where acute caffeine
increased eccentric PT compared to the placebo trial.
3.3. Total Work
3.3.1. Elbow Extension Total Work
For concentric and eccentric TW of the elbow extensors there was no significant interac-
tions (Table 3: p > 0.065 ηp2 > 0.003), no main effects of Group (Table 3: p > 0.762 ηp2 > 0.003),
Treatment (Table 3: p > 0.151 ηp2 > 0.072), or Time (Table 3: p = 0.578 ηp2 > 0.006). However,
there were significant main effects of Set (Table 3: p = 0.001 ηp2 > 0.527) with performance at
Set1 being higher than that at Set2 and Set3 (J) (Table 3: p < 0.001, d > 0.36) and performance
at Set2 being higher than that at Set3 (Table 3: p = 0.001, d > 0.33).
3.3.2. Elbow Flexion Total Work
For concentric and eccentric TW of the elbow flexors, there was a significant interac-
tion between Time*Set (Table 3: p < 0.047 ηp2 > 0.113). Pairwise comparison for concentric
TW indicated that pre-exercise intervention, Set1 TW was higher than post-intervention
(Table 3: p = 0.002, d > 0.30). Furthermore, both pre-and post-the intervention performance
in Set2 and Set3 was significantly lower than at Set1 (Table 3: p < 0.001) for both concentric
and eccentric TW. No other significant interactions were identified (Table 3: p > 0.096
ηp
2 < 0.931) and there was no main effect of Group (Table 3: p > 0.271 ηp2 < 0.035). Con-
centric TW was not affected by Treatment (Table 3: p = 0.231 ηp2 = 0.051); however, there
was a main effect of Treatment for eccentric TW (Table 3: p = 0.003 ηp2 = 0.272), where TW
following acute caffeine treatment was greater than the placebo treatment.
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Table 3. Acute effect of caffeine treatment (3 mg·kg−1) pre and post-7-week resistance training on concentric and eccentric
TW (Nm) of the elbow and knee flexors and extensors.
Caffeine Intervention Group Placebo Intervention Group
Set
Acute Placebo Acute Caffeine Acute Placebo Acute Caffeine
Pre-Int Post-Int Pre-Int Post-Int Pre-Int Post-Int Pre-Int Post-Int
Elbow Extension
Con Set 1 393 ± 168 370 ± 66 348 ± 75 411 ± 228 344 ± 87 349 ± 105 369 ± 137 356 ± 66
Set 2 298 ± 140 281 ± 63 266 ± 60 328 ± 230 277 ± 86 278 ± 63 311 ± 124 314 ± 85
Set 3 232 ± 138 216 ± 53 216 ± 74 268 ± 213 213 ± 78 220 ± 61 246 ± 112 262 ± 98
Ecc Set 1 428 ± 309 381 ± 91 410 ± 118 421 ± 193 366 ± 202 398 ± 132 444 ± 167 425 ± 141
Set 2 334 ± 253 313 ± 72 334 ± 94 339 ± 225 303 ± 161 336 ± 108 478 ± 533 346 ± 131
Set 3 279 ± 266 248 ± 52 265 ± 67 295 ± 208 237 ± 127 278 ± 104 303 ± 130 280 ± 95
Elbow Flexion
Con Set 1 486 ± 116 458 ± 91 490 ± 102 463 ± 71 500 ± 119 463 ± 107 523 ± 129 478 ± 92
Set 2 377 ± 84 361 ± 70 369 ± 90 360 ± 82 395 ± 77 383 ± 104 412 ± 68 403 ± 76
Set 3 312 ± 69 319 ± 78 321 ± 87 315 ± 71 341 ± 67 325 ± 68 362 ± 83 354 ± 80
Ecc Set 1 538 ± 166 * 463 ± 87 ˆ 551 ± 134 * 505 ± 131 ˆ 493 ± 187 * 521 ± 205 ˆ 587 ± 194 * 537 ± 156 ˆ
Set 2 416 ± 149 * 376 ± 80 ˆ 431 ± 118 * 402 ± 126 ˆ 408 ± 136 * 453 ± 149 ˆ 472 ± 133 * 448 ± 97 ˆ
Set 3 345 ± 116 * 352 ± 89 ˆ 373 ± 85 * 345 ± 95 ˆ 372 ± 114 * 389 ± 104 ˆ 425 ± 135 * 409 ± 122 ˆ
Knee Extension
Con Set 1 612 ± 359 *# 1010 ± 361# 1080 ± 375 * 1045 ± 374 648 ± 402 *# 1036 ± 250 # 981 ± 304 * 1120 ± 279
Set 2 553 ± 342 *# 980 ± 351 # 989 ± 278 * 971 ± 296 603 ± 403 *# 1006 ± 237 # 1013 ± 164* 1003 ± 189
Set 3 495 ± 325 *# 856 ± 250 # 911 ± 265 * 893 ± 252 598 ± 454 *# 903 ± 169 # 967 ± 206 * 915 ± 124
Ecc Set 1 586 ± 267 1036 ± 383 1179 ± 417 1144 ± 466 738 ± 407 1251 ± 423 1223 ± 401 1246 ± 275
Set 2 503 ± 261 1011 ± 353 1084 ± 351 1061 ± 453 552 ± 345 1238 ± 411 1213 ± 320 1176 ± 253
Set 3 435 ± 216 918 ± 301 990 ± 314 940 ± 368 572 ± 334 1171 ± 375 1110 ± 370 1146 ± 304
Knee Flexion
Con Set 1 524 ± 99 574 ± 179 569 ± 179 644 ± 169 547 ± 152 542 ± 127 563 ± 144 542 ± 144
Set 2 442 ± 114 521 ± 173 485 ± 137 568 ± 104 448 ± 115 449 ± 96 477 ± 132 492 ± 150
Set 3 404 ± 116 467 ± 140 476 ± 125 503 ± 97 379 ± 109 421 ± 110 450 ± 120 441 ± 108
Ecc Set 1 505 ± 178 * 630 ± 241 ˆ 601 ± 235 * 699 ± 261 ˆ 610 ± 214 * 657 ± 210 ˆ 668 ± 235 * 630 ± 166 ˆ
Set 2 496 ± 268 537 ± 200 528 ± 172 610 ± 220 514 ± 168 * 542 ± 165 ˆ 589 ± 213 * 578 ± 173 ˆ
Set 3 422 ± 214 516 ± 193 482 ± 163 561 ± 203 430 ± 112 * 536 ± 182 ˆ 551 ± 199 * 545 ± 126 ˆ
Note: Values are represented as means ± SD, TW = Total Work, Con = Concentric, Ecc = Eccentric, Pre-Int= Pre-training intervention, and
Post-Int= Post-training intervention, matching * represents a significant effect of caffeine prior to the intervention, matching ˆ represents a
significant effect of caffeine post-intervention, matching # represents a significant difference on total work post the intervention.
3.3.3. Knee Extension Total Work
For eccentric TW of the knee extensors there were no significant interactions (Table 3:
p > 0.130 ηp2 > 0.032). For concentric TW there was a significant Time*Treatment interaction
(Table 3: p = 0.001 ηp2 = 0.350). Pairwise comparison indicated an increase in TW post-
intervention (Table 3: p = 0.001, d < 1.04). Furthermore, TW was significantly increased in
the caffeine trial prior to the exercise intervention (Table 3: p = 0.001, d < 1.34), however,
post-intervention there was no significant difference between the caffeine and placebo trial
(Table 3: p = 0.599, d < 0.18). For concentric TW there were no other significant interactions
(Table 3: p > 0.184 ηp2 < 0.933). For both concentric and eccentric TW there was no effect of
Group (Table 3: p > 0.494 ηp2 < 0.018). Eccentric TW reported no other main effects (Table 3:
p > 0.140 ηp2 < 0.077) but for concentric TW there was a main effect of Set (Table 3: p = 0.001
ηp
2 = 0.400). TW at Set1 was higher than Set2 and Set3 (Table 3: p < 0.010, d > 0.11) and
performance at Set2 was higher than that at Set3 (Table 3: p = 0.001, d > 0.009).
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3.3.4. Knee Flexion Total Work
For concentric TW of the knee flexors there were no significant interactions (Table 3:
p > 0.113 ηp2 < 0.075), but for eccentric TW there was a Group*Treatment*Set interaction
(Table 3: p = 0.029 ηp2 = 0.119). Pairwise comparison indicated that there was no effect
of Group (Table 3: p > 367, d = 0.12–2.00). However, eccentric TW was greater in the
placebo group during caffeine trials (Table 3: p = 0.046, d > 0.13). In the caffeine group
Set1 TW was significantly higher during the caffeine trials (Table 3: p = 0.029, d > 0.26).
For eccentric TW there was no main effect of Time (Table 3: p = 0.007 ηp2 = 0.235) and
for concentric TW there was no main effect of Group (Table 3: p = 0.256 ηp2 = 0.046) or
Time (Table 3: p = 0.148 ηp2 = 0.073). However, concentric TW was significantly increased
following caffeine treatment (Table 3: p = 0.014 ηp2 = 0.198). Concentric and eccentric TW
was effected by Set (Table 3: p = 0.001 ηp2 = 0.629) with performance at Set1 being higher
than that at Set2 and Set3 (Table 3: p < 0.010, d > 0.61) and performance at Set2 being higher
than that at Set3 (Table 3: p = 0.001, d > 0.014).
3.4. Rate of Perceived Exertion
3.4.1. Elbow Extension Rate of Perceived Exertion
RPE following repeated MVC of the elbow extensors there were significant Group*Time
(Table 4: p = 0.025 ηp2 = 0.167), Time*Treatment (Table 4: p = 0.003 ηp2 = 0.267), Time*Set
(Table 4: p = 0.011 p = 0.025 ηp2 = 0.186), and Treatment*Set (Table 4: p = 0.050 p = 0.025
ηp
2 = 0.115) interactions. Pairwise comparison indicated no group difference in RPE fol-
lowing MVC (Table 4: p < 0.437, d < 0.62). The caffeine group had increased RPE following
MVC post-training intervention (Table 4: p = 0.001 d > 0.097). Furthermore, the placebo
group had a treatment effect post-intervention, with RPE during the caffeine trial being
higher than the placebo trial (Table 4: p < 0.006) at Set2 (Table 4: d = 0.87) and Set3 (Table 4:
d = 0.76). Irrespective of treatment, RPE following Set3 was higher than that following
completion of Set1 and Set2 (Table 4: p = 0.001 d > 0.97.) There were no other significant
interactions (Table 4: p > 0.085 ηp2 < 0.936).
Table 4. Acute effect of caffeine treatment (3 mg·kg−1) pre and post-7-week resistance training on RPE following re-
peated MVC.
Caffeine Intervention Group Placebo Intervention Group
Acute Placebo Acute Caffeine Acute Placebo Acute Caffeine
Pre-Int Post-Int Pre-Int Post-Int Pre-Int Post-Int Pre-Int Post-Int
Elbow Extension
Set1 14 ± 3 16 ± 2 13 ± 2 16 ± 2 14 ± 2 14 ± 3 14 ± 2 15 ± 2
Set2 15 ± 2 17 ± 2 15 ± 2 17 ± 2 15 ± 2 15 ± 3 ˆ 15 ± 2 17 ± 1 ˆ
Set3 17 ± 2 19 ± 2 16 ± 2 19 ± 1 17 ± 1 16 ± 3 ˆ 17 ± 2 18 ± 2 ˆ
Elbow Flexion
Set1 14 ± 3 16 ± 2 14 ± 2 16 ± 2 14 ± 2 17 ± 2 14 ± 2 16 ± 2
Set2 15 ± 2 18 ± 2 16 ± 2 17 ± 2 16 ± 2 18 ± 1 15 ± 2 18 ± 1
Set3 17 ± 2 19 ± 2 17 ± 2 18 ± 2 17 ± 1 19 ± 1 17 ± 2 19 ± 1
Knee Extension
Set1 13 ± 3 17 ± 2 14 ± 2 16 ± 3 13 ± 3 16 ± 2 14 ± 2 16 ± 2
Set2 14 ± 3 18 ± 2 15 ± 2 17 ± 3 13 ± 3 18 ± 1 16 ± 2 18 ± 1
Set3 15 ± 2 19 ± 2 17 ± 2 18 ± 3 14 ± 3 19 ± 1 17 ± 2 19 ± 1
Knee Flexion
Set1 14 ± 2 16 ± 1 14 ± 2 16 ± 2 14 ± 3 16 ± 2 14 ± 2 16 ± 3
Set2 15 ± 2 17 ± 2 15 ± 2 17 ± 2 15 ± 2 17 ± 1 16 ± 2 17 ± 2
Set3 17 ± 2 19 ± 2 17 ± 2 18 ± 2 17 ± 2 19 ± 1 17 ± 2 19 ± 1
Note: Values are represented as means ± SD, RPE = Rate of Perceived Exertion, MVC= Maximum voluntary contraction, Pre-Int = Pre-
training intervention, and Post-Int = Post-training intervention, matching ˆ represents a significant effect of caffeine post-intervention.
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3.4.2. Elbow Flexion Rate of Perceived Exertion
For RPE following repeated MVC of the elbow flexors, there was a significant Time*Set
interaction (Table 4: p = 0.001 ηp2 = 0.222). Pairwise comparisons indicated an increase in
RPE following MVC post-exercise intervention (Table 4: p = 0.001 d > 0.48). Both pre-and
post-exercise intervention, RPE following Set 3 was higher than that following Set 1 and
Set 2 (Table 4: p < 0.001 d > 0.62). There were no other significant interactions (Table 4:
p > 0.072 ηp2 < 0.064) and no main effect of Group (Table 4: p = 0.771 ηp2 < 0.014) or
Treatment (Table 4: p = 0.961 ηp2 = 0.001).
3.4.3. Knee Extension Rate of Perceived Exertion
For RPE following repeated MVC of the knee extensors, there was a significant
Group*Time*Set interaction (Table 4: p = 0.017 ηp2 = 0.135). Pairwise comparison indicated
no group effect pre-or post-exercise intervention (Table 4: p > 0.130 d < 2.18). However, both
treatment groups indicated increased RPE post the exercise intervention across (Table 4:
p < 0.001 d > 0.40). RPE following Set3 was significantly higher than Set1 and Set2 (Table 4:
p < 0.001 d< 2.18.). There was also a Time*Treatment interaction (Table 4: p = 0.001
ηp
2 = 0.396), where RPE was higher post-intervention in both treatments (Table 4: p = 0.001
d > 0.97). Furthermore, prior to the exercise intervention, RPE was significantly higher
following caffeine treatment (Table 4: p = 0.001 d > 0.76).
3.4.4. Knee Flexion Rate of Perceived Exertion
For RPE following repeated MVC of the knee flexors, there was no significant interac-
tion (Table 4: p > 0.061 ηp2 < 0.975). However, there was a main effect with Time (Table 4:
p = 0.001 ηp2 = 0.748) with post-training intervention RPE being increased. There was also
a main effect with Set (Table 4: p = 0.001 ηp2 = 0.898) with RPE following Set3 being higher
than Set1 and Set2. There were no main effects of Group (Table 4: p = 0.760 ηp2 = 0.002) or
Treatment (Table 4: p = 0.666 ηp2 = 0.006).
3.5. Readiness to Invest Effort and Felt Arousal Scale
For RTE Physical, RTE Mental, and FAS there were no significant interactions (Table
S1: p > 0.060 ηp2 > 0.001). RTE Physical, RTE Mental, and FAS were significantly affected by
time post-ingestion (Table S1: p < 0.001 ηp2 > 0.245). Both RTE Physical and FAS reported
45 min post-treatment were significantly higher than pre, 15- and 30-min post-treatment
(Table S1: p < 0.015 in all cases d < 0.68). However, RTE Mental 30 min post-treatment was
higher than pre, 15-, and 45-min post-treatment (Table S1: p < 0.050 in all cases d < 0.30).
There were no significant main effects of Group (Table S1: p > 0.150 ηp2 > 0.007), Time
(Table S1: p > 0.057 ηp2 > 0.124) or Treatment (Table S1: p > 0.415 ηp2 > 0.003).
3.6. 1RM
For 1RM performance, there were no significant Group*Time interaction (Figure 4:
p < 0.962, ηp2 < 0.008). Following the resistance training intervention, 1RM improved in
all lifts (Figure 4: p < 0.001 ηp2 > 0.633). There was no significant effect of Group in all
exercises (Figure 4: p > 0.850 ηp2 < 0.071) apart from DL (Figure 4: p = 0.001 ηp2 = 0.493)
with the placebo group having a greater performance during 1RM assessment.
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3.7. Intervention Repetitions until Failure
For all exercises, there were no significant interactions (Figure 5: p = 0.998). However,
RTF across the training intervention was higher in the caffeine group for SSP, SQ, DL, and
HC (Figure 5: p < 0.037 d < 0.13). The placebo group outperformed the caffeine group in PC
(Figure 5: p = 0.005 d < 0.18), and there were no between-group differences for CP (Figure 5:
p = 0.618). For all exercises, there was also a main effect of Session (Figure 5: p < 0.005).
Whilst there were some differences between specific sessions, there were clearer trends
for an increase in CP, SSP, DL, and PC RTF as the duration of the intervention increased.
Furthermore, for all exercises, there was a main effect of Set with RTF being higher in Set1
compared to Set2 (Figure 5: p < 0.001 d < 0.14).
3.8. Intervention RPE
For both SQ and HC, sessional RPE of the caffeine group was lower than that of the
placebo group (Table S2: p < 0.035 d < 0.62). For CP, SQ, and DL there was a main effect of
Session (Table S2: p < 0.034). Pairwise comparisons show some session-specific differences
for SQ and DL, but no clear trends. Furthermore, for all exercises, there was a main effect
of Set, with RPE being higher in Set1 compared to Set2 (Table S2: p < 0.044 d > 0.49). There
were no significant interactions (Table S2: p > 0.072).
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4. Discussion
Data from the present study indicate that prior to the training intervention the acute
ingestion of 3 mg·kg−1 caffeine increased specific measures of muscular strength in a
muscle- and contractile mode-specific manner. Twice weekly ingestion of caffeine during
the 7-week resistance-training program had little effect on caffeine’s ability to evoke an
acute benefit, with many of the reported caffeine-induced improvements in muscular
strength still prevalent in both the caffeine and placebo groups when reassessed upon
completion of the training intervention. Although the seven-week resistance training
intervention significantly improved 1RM and specific measures of maximal isokinetic
torque—other than the PT of the knee extensors, which was only improved in the caffeine
treated group—benefits were not statistically different between the group that consumed
caffeine prior to each session compared to those that consumed a placebo. This similar
increase in performance upon completion of the exercise intervention was apparent despite
the greater number of resistance exercise repetitions performed for numerous exercises
in the caffeine group across the course of the intervention. As such, the results of this
study demonstrate that: (1) 3 mg·kg−1 may be useful to evoke acute enhancements in
muscular strength; (2) relatively short-term chronic ingestion of 3 mg·kg−1 of caffeine may
not lead to habituation to its effects; (3) chronic caffeine supplementation for 7-week may
not enhance resistance-training induced gains in strength.
4.1. Acute Effects of Caffeine on Muscular Strength
Recent meta-analyses indicate that acute caffeine consumption may enhance muscular
strength, including strength assessed using isokinetic dynamometry [1,3,5]. In line with
these findings, the results of the present study indicate that acute caffeine ingestion in-
creased specific measures of PT and TW when compared to a placebo. More specifically, an
acute ergogenic effect of caffeine was observed for: (a) eccentric PT of the elbow extensors
at higher angular velocities and concentric PT of the elbow flexors; (b) elbow flexion TW;
(c) eccentric PT of the knee flexors; and (d) knee extension TW (pre-intervention) and
knee flexion TW (both pre-and post-intervention). Based on these data and in accordance
with previous work [17–20], it can be concluded that caffeine has a muscle- and contractile
mode-specific effect. Whilst our data indicate caffeine-induced benefits for both concentric
and eccentric PT, there appears to be a greater number of benefits for upper body muscula-
ture. This contradicts previously published work indicating superior benefits for lower
limb musculature, attributed to mechanisms of the central nervous system stemming a
greater increase in muscular recruitment within larger muscle groups [7]. Conversely, a
more recent meta-analysis by Grgic et al. [3] indicated that caffeine effects on strength and
power were more evident in the upper body.
Mechanistically, the ability of caffeine to evoke improved exercise performance is
primarily attributed to its effects as a central adenosine receptor antagonist [53–56]. Caffeine
and adenosine share similar molecule structures. Because of their similar structure, they
compete for adenosine binding sites resulting in a surge excitatory neurotransmitter causing
reduced pain perception [22,57], a rise in motor unit recruitment, and improved excitation-
contraction coupling [22,58,59]. Caffeine may act directly on skeletal muscle [60–63],
increasing the release and myofibril sensitivity to Ca+2 [64–66], resulting in increased cross-
bridge formation. In support, the exposure of isolated skeletal muscle to physiological
concentrations of caffeine has been shown to evoke increased muscular power [22].
Although it was not the purpose of the present study to determine the mechanisms
underpinning the acute effects of caffeine on muscular strength, the influences of some
of these mechanisms can be determined. When measured in the arm of the experiment
examining the acute effects of caffeine, post-exercise RPE was in the most part unaffected
by caffeine, and on some occasions was increased following acute caffeine ingestion. This
coincides with previous work where caffeine ingestion had a limited effect on perceived
effort or pain in scenarios where exercise performance was unchanged [39,67,68] or im-
proved [69–71] following caffeine consumption. Intersessional RPE following CP and PC
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exercise was not different between the groups. However, RPE following SSP, SQ, DL, and
HC was reduced in the caffeine group. This may in part support the concept of caffeine as
a pain suppressor in some circumstances, though this should be interpreted with caution
given that this part of the protocol used a between subject’s design.
Interestingly, caffeine did not have an effect on RTE physical and mental effort when
measured in the arm of the experiment examining the acute effects of caffeine. This
coincides with previous research [68,72]. Whilst these findings point to physiological
mechanisms being the cause of the documented effects, the impact of caffeine on arousal
during the exercise as a mechanism cannot be ruled out. To some extent, the results of
perceptual measures needed to be interpreted with caution given their sensitivity to change
following caffeine ingestion have not been robustly explored.
4.2. Habituation to Chronic Caffeine Consumption
There is a debate in the literature as to whether the acute benefits of caffeine on physical
performance are reduced following chronic exposure, with some evidence indicating habit-
uation to caffeine’s effect [12,13] and others suggesting no habituation effects [11,73–75]. In
the present study, the acute effects of caffeine on PT and TW were reasonably uniform prior
to and following the training intervention. For example, acute caffeine-induced increases
in eccentric elbow extension PT, concentric elbow flexion PT, eccentric knee flexion PT,
eccentric elbow flexion TW, and concentric knee flexion TW that was demonstrated prior to
the intervention were still prevalent in the caffeine intervention group when acute caffeine
responses were reassessed post-intervention.
These results suggested that consuming 3 mg·kg−1 of caffeine, twice per week for
7-weeks, in a population of 30 moderate habitual caffeine consumers, did not reduce the
caffeine’s ergogenicity. Although there are varying methodological approaches to assess
caffeine habituation, the findings of the present work agree with previous evidence that
indicates that caffeine evokes equivalent performance-enhancing effects in low and high
habitual caffeine users [1,8,11,74,76]. For example, Gonçalves et al. [11] demonstrated
that 6 mg·kg−1 of caffeine improved cycling time trial performance in low (58 mg/day),
moderate (143 mg/day), and high (351 mg/day) habitual caffeine users. Still, although
models stratifying participants by typical caffeine consumption habits for examining the
potential for habituation have value, the results from these studies may be limited by the
reliance on subjective caffeine recall used to quantify caffeine use.
The disparity between the current data and studies that have directly measured and
have indicated habituation to caffeine effects is likely due to differences in the population
characteristics, the dose, and duration of caffeine administration, and the outcome variables
assessed. For example, Beaumont et al. [13] included low habitual caffeine consumers
(<75 mg/day) randomly assigned to consume placebo or caffeine (1.5–3 mg·kg−1) for 28
days. Results indicated that the acute effect of caffeine on cycling performance was evident
pre-supplementation and was no longer apparent after 4 weeks of caffeine supplementation.
Lara et al. [12] used a caffeine dose of 3 mg·kg−1 supplementation for 20 consecutive days,
during which performance in a Wingate test was evaluated. While caffeine increased
cycling power, the ergogenic effects attenuated over the course of the study, suggesting
progressive tolerance. Indirect assessments of the impact of habituation have also be made
by studies that stratify their participant groups by habitual caffeine use. Several studies
demonstrate an ergogenic effect in high caffeine users across anaerobic and aerobic modes
of exercise [1,11,73,74,76]. Studies examining caffeine habituation specifically for measures
of muscular strength are limited, and as such, these findings make a novel contribution to
the literature.
4.3. Effects of Chronic Caffeine Consumption on Resistance Training
Irrespective of the supplement provided, the training intervention resulted in a signif-
icant increase in all assessments of 1RM and specific measures of PT and TW. The more
pronounced effects of the training intervention of 1RM were expected due to training
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specificity [77]. Post-intervention concentric PT of the knee extensors at all angular ve-
locities and eccentric PT at 60 deg/s was improved only in the caffeine group. Other
improvements in PT, TW, and measures of 1RM were uniform across the caffeine and
placebo-treated groups, indicating a limited effect of chronic caffeine ingestion to augment
adaptations to resistance exercise. The chronic effect of caffeine as a nutritional strategy
to support training has received little attention. Our findings differ from the findings
presented by Kemp et al. [9] who demonstrated that strength-trained participants that con-
sumed 3 mg·kg−1 caffeine before each session of a 6-week resistance training intervention
had superior improvements in the bench press and squat 1RM compared to those that
consumed a placebo for the duration of the intervention. However, our data support work
by Giraldez-Costas et al. and Pakulak et al. [16,78] who indicated no significant differences
in 1RM strength gains between caffeine and placebo groups following 4 or 6 weeks of
resistance training intervention.
We progress previous findings by demonstrating this relationship following a longer
intervention period and across a larger range of strength assessments considering not only
1RM in different exercises but also maximal voluntary concentric and eccentric muscle
functions across a range of joint angular velocities. The disparity between the present
findings and those of Kemp et al. [9] may be related to differences between populations.
Kemp et al. [9] used specifically strength-trained participants, and it has been suggested
that caffeine may have a greater effect on this population as compared to untrained individ-
uals [3,79,80]. Whereas this may in part be related to improved repeatability of performance
in specifically trained individuals [3,79,80], this suggestion has some mechanistic underpin-
ning. Previous research suggests that trained individuals have a greater adenosine receptor
density compared to those who are less trained or untrained [81]. Those with an increased
adenosine receptor density may evoke amplified caffeine [82]. However, this is speculative
and requires further investigation in light of evidence reporting similar caffeine-induced
benefits in performance in both trained and untrained participants [80,83], and in some
cases, increased responses in untrained individuals [80].
This study is the first to monitor the acute effect of caffeine during each session of a
training intervention. Interestingly, across the training intervention, RTF was higher in
SSP, SQ, DL, and HC for the caffeine group. While this may add further weight to the
acute benefits of caffeine, it demonstrates the small but significant increase in the relative
total weight lifted was not substantial enough in magnitude to evoke a superior training
response. Furthermore, sessional RPE was either unchanged or in some cases decreased in
the caffeine group, this again indicates that the ability of caffeine to suppress perception of
pain/ effort may be more prevalent during sustained contractions [40,67,68].
5. Limitations and Future Direction
The present study offers valuable insight with respect to the effects of chronic caffeine
supplementation as a nutrition strategy to augment resistance training, though it is not
without limitation. Firstly, a resistance-training program with a weekly training frequency
greater than that adopted in the present study would likely evoke greater adaptations in
the measured outcomes [84]. However, the training frequency used in the present study
was designed to coincide with other commitments of the club. That said, the training
regime adopted successfully improved measures of muscular strength and therefore was
appropriate to address the experimental aims.
Our data indicate a small but significant increase in training volume across the course
of the intervention, whilst this did not manifest in an enhanced training response in the
measured outcomes there is the possibility that a sustained increase in training volume
over a longer period may evoke enhanced adaptations. This is an avenue for future
investigation.
We did not measure genetic influencers that potentially may influence the caffeine’s
performance-enhancing effect [3,85,86]. A recent review has indicated that the CYP1A2
and the ADORA2A may be important influencers of the caffeine response [87]. Future
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work should consider genetic influences that underpin caffeine’s effect when assessing the
impact of chronic ingestion as a method to elicit superior training adaptations.
Furthermore, this study used individuals that were physically conditioned but not
specifically resistance trained. Although the demonstrated effects may be relevant to a
broad population that is relatively naive to resistance training, they may not be general-
isable to individuals that are specifically resistance trained. Future work should look to
directly compare trained against untrained participants using a similar approach to that
adopted in the present study. Future work should also look to repeat this study using
different doses of caffeine. We selected 3 mg·kg−1 for the present study as it typically
considered the minimum dose needed to evoke an improved exercise performance [88–90]
and more closely represents caffeine consumed from commercially available products.
Previous work exploring the acute effects of caffeine on physical performance is focused
on males [1–5,7] and there is recent growing interest in establishing the caffeine response in
females [91]. Whilst it seems that the effects of caffeine on resistance exercise performance
are similar between males and females [92], future similar studies performed with females
as study participants are nevertheless needed.
6. Conclusions
This study examined the acute effects of 3 mg·kg−1 caffeine consumption on muscular
strength and explored if chronic use of caffeine could be used as an effective nutrition
strategy to augment the response to resistance training. The data presented herein indicate
a muscle and contractile mode-specific acute benefit of caffeine consumption, effects
that were not dampened following twice-weekly consumption over the time course of a
seven-week resistance training intervention. Whilst the training intervention resulted in
significant improvements in 1RM performance and specific measures of isokinetic PT and
TW of the upper and lower limb musculature, for the most part, the effects were equivalent
in both the group ingesting caffeine and in the group ingesting a placebo. These effects were
prevalent despite a small but significant increase in RTF across the training intervention in
the caffeine group. In summary, our results infer that caffeine may be beneficial to evoke
acute improvements in muscular strength but has limited benefits across the course of a
resistance training intervention.
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